Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction

Published:2020-11-01 Issue:11 Volume:5 Page:1236
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Gaziano Thomas A.¹,Fonarow Gregg C.²³,Velazquez Eric J.⁴,Morrow David A.¹,Braunwald Eugene¹,Solomon Scott D.¹

Affiliation:

1. Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Ahmanson-UCLA Cardiomyopathy Center, Ronald Reagan UCLA Medical Center, Los Angeles, California

3. Associate Editor for Health Care Quality and Guidelines, JAMA Cardiology

4. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2769180/jamacardiology_gaziano_2020_oi_200048_1605207393.01197.pdf

Reference27 articles.

1. A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States.;Voigt;Clin Cardiol,2014

2. Angiotensin-neprilysin inhibition versus enalapril in heart failure.;McMurray;N Engl J Med,2014

3. Cost-effectiveness analysis of sacubitril/valsartan vs enalapril in patients with heart failure and reduced ejection fraction.;Gaziano;JAMA Cardiol,2016

4. Angiotensin-neprilysin inhibition in acute decompensated heart failure.;Velazquez;N Engl J Med,2019

5. Heart failure disease management programs: a cost-effectiveness analysis.;Chan;Am Heart J,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure;Journal of the American College of Cardiology;2024-09

2. Effect of sacubitril/valsartan on hospital readmissions in heart failure with reduced ejection fraction in Saudi Arabia: A multicenter retrospective cohort study;Medicine;2024-07-26

3. Safety and Tolerability of Initiating Sacubitril-Valsartan With Spironolactone During Hospitalization for Acute Decompensated Heart Failure;Journal of Pharmacy Practice;2024-07-18

4. Budget impact analyses for treatment of heart failure. A systematic review;Heart Failure Reviews;2024-03-16

5. Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA‐HF Trials;Journal of the American Heart Association;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3